Status:
COMPLETED
4 Repeat Tauopathy Neuroimaging Initiative
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute on Aging (NIA)
Conditions:
Progressive Supranuclear Palsy
Corticobasal Degeneration
Eligibility:
All Genders
45-90 years
Brief Summary
The purpose of this study is to evaluate several different tests, including brain imaging, eye movement testing, body fluid samples, measurements of memory and other thinking abilities, and measures o...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Progressive Supranuclear Palsy or Corticobasal Degeneration
- Must have a reliable study partner who has frequent contact with the subject
- Willing and able to undergo testing procedures
Exclusion
- Significant neurological disease other than PSP or CBD
- Presence of pacemakers, aneurysm clips, artificial heart valves, ear implants, metal fragments or foreign objects in the eyes, skin or body
Key Trial Info
Start Date :
January 10 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2016
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT01804452
Start Date
January 10 2011
End Date
March 1 2016
Last Update
May 8 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94158
2
John Hopkins University
Baltimore, Maryland, United States, 21218